Savara Pharmaceuticals Obtains $4,493,581 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a92e56e2-f373-4ee1-a42b-0675f1444db6
Date
6/11/2014
Company Name
Savara Pharmaceuticals
Mailing Address
900 S. Capital of Texas Highway Austin, TX 78746 USA
Company Description
Savara is a pharmaceutical company developing novel respiratory therapeutics utilizing our proprietary NanoCluster dry powder aerosol drug delivery platform.The aerosols are assembled directly from nanoparticles of an existing therapeutic and delivered via oral pulmonary or nasal routes using off-the-shelf dry powder inhalers.
Website
http://www.savarapharma.com
Transaction Type
Debt
Transaction Amount
$4,493,581
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor